Eckert & Ziegler BEBIG S.A. | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
27,838.00
28,816.00
31,088.00
24,884.00
25,894.00
Cost of Goods Sold (COGS) incl. D&A
14,174.00
16,397.00
19,451.00
12,724.00
14,724.00
Gross Income
13,664.00
12,419.00
11,637.00
12,160.00
11,170.00
SG&A Expense
13,421.00
15,429.00
15,460.00
12,698.00
9,939.00
EBIT
116.00
3,030.00
3,890.00
522.00
1,231.00
Unusual Expense
1,641.00
277.00
1,039.00
1,125.00
595.00
Non Operating Income/Expense
201.00
1,448.00
2,155.00
2,180.00
416.00
Interest Expense
465.00
716.00
881.00
563.00
270.00
Pretax Income
2,555.00
1,521.00
3,384.00
543.00
2,069.00
Income Tax
905.00
1,526.00
674.00
3.00
740.00
Equity in Affiliates
-
-
8.00
7.00
-
Consolidated Net Income
3,460.00
3,047.00
4,050.00
553.00
1,329.00
Net Income
3,460.00
3,047.00
4,050.00
553.00
1,329.00
Net Income After Extraordinaries
3,460.00
3,047.00
4,050.00
553.00
1,329.00
Net Income Available to Common
3,460.00
3,047.00
4,050.00
553.00
1,329.00
EPS (Basic)
2.00
1.70
2.30
0.27
0.57
Basic Shares Outstanding
1,755.40
1,755.40
1,755.40
2,078.10
2,330.00
EPS (Diluted)
1.97
1.74
2.31
0.27
0.57
Diluted Shares Outstanding
1,755.40
1,755.40
1,755.40
2,078.10
2,330.00
EBITDA
2,109.00
1,287.00
1,352.00
1,628.00
3,703.00
Other Operating Expense
127.00
20.00
67.00
16.00
-
Non-Operating Interest Income
1,062.00
500.00
271.00
573.00
97.00

About Eckert & Ziegler BEBIG

View Profile
Address
rue Jules Bordet
Seneffe WA 7180
Belgium
Employees -
Website http://www.bebig.com
Updated 09/14/2018
Eckert & Ziegler BEBIG SA engages in the provision of medical device. Its products include prostate seed brachytherapy, brain seed brachytherapy, high dose rate brachytherapy, ophthalmic brachytherapy, and radiotherapy accessories. The company was founded on February 15, 1996 is headquartered in Seneffe, Belgium.